Robinson Pharma Expands Costa Mesa, California, Operations
09/17/2019
According to company officials, this new addition brings Robinson Pharma to now six buildings and totaling over 650,000 square feet. The new state-of-the-art eco-friendly facility will serve as RPI’s newest expansion to accommodate its continuing business growth.
The building spans 100,276 square feet and sits on more than five acres of land. RPI has committed to invest $20M in this facility to better serve its customers with the latest advances in nutraceutical contract manufacturing and quality assurance.
With these new investments, RPI said it will keep pace with the growing demand for wellness products and continue in its vision to provide the best in service in the supplement industry.
Robinson Pharma, Inc., is a Southern California-based full-service contract manufacturer of dietary supplements with over 650,000 square feet of production capabilities of capsules, softgels, tablets, powders, and liquids. Robinson Pharma, Inc. possesses multiple third-party certifications of current Good Manufacturing Practice (cGMP) and Safe Quality Food (SQF) compliance from well-reputed organizations, such as Eurofins, NPA, NSF, and UL for supplement manufacturing in the United States.
Project Announcements
France-Based Sartorius Stedim Plans Marlborough, Massachusetts, Bioprocess Operations
12/10/2024
357 Brewers Expands Myrtle Beach, South Carolina, Operations
12/05/2024
Koch Foods Expands Morton, Mississippi, Operations
12/04/2024
Irving Tissue Expands Macon, Georgia, Production Operations
12/03/2024
General Mills Expands Hannibal, Missouri, Production Operations
12/03/2024
US Foods Expands Buda, Texas, Distribution Operations
12/03/2024
Most Read
-
How Automation Is Actually Closing the Labor Gap
Q4 2024
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
The Role of Rail in Industrial Development
Q4 2024
-
Hydrogen Industry in Canada: A Global Leader in the Clean Energy Revolution
Q3 2024
-
Which AI Tools Work for Job Recruiters?
Q3 2024
-
Permitted Power Capacity Foreshadows Health of Regional Economies
Q3 2024
-
Navigating Non-Disclosure Agreements in Site Selection
Q3 2024